BioNTech's second act: can it transform the fight against cancer? | Financial Times
Pfizer and BioNTech Start Filing for Vaccine Approval in Europe | Barron's
BioNTech founder Ugur Sahin joins world's 500 richest after UK approves Covid vaccine
Ugur Sahin
Biontech-CFO Sierk Poetting ist CFO des Monats
Three Billionaires Behind Pfizer's Vaccine Partner BioNTech Are $2 Billion Richer After It Announces Covid-19 Vaccine Results
BioNTech, Moderna executives' wealth gets a massive boost from Covid-19 vaccines, Hurun list shows | South China Morning Post
Pfizer and BioNTech Vaccine Could Be Ready By the End of November. We're All Winners. | Barron's
BioNTech profile: Firm working with Pfizer for COVID-19 vaccine
Gesundheit: Biontech-Chef: Haben noch harte Monate vor uns | ZEIT ONLINE
New vaccine billionaires gain wealth as Moderna, Pfizer shares soar
Chart: Pfizer Revenue Boosted by Covid-19 Drugs | Statista
Meet The 50 Doctors, Scientists And Healthcare Entrepreneurs Who Became Pandemic Billionaires In 2020
Holger Zschaepitz on Twitter: "#BionTech Founder Ugur Sahin just reached another milestone: He joined the world's 500 richest people w/net worth of ~$5bn. He is the 34th wealthiest man in #Germany after
/cloudfront-us-east-2.images.arcpublishing.com/reuters/Q7THZCFMT5M2VG6VXWD5YULRFY.jpg "BioNTech to expand trial programme for more anti-Omicron vaccine options | Reuters")
BioNTech to expand trial programme for more anti-Omicron vaccine options | Reuters
Chart: How COVID-19 Vaccines Changed Pharma Company Profits | Statista
BioNTech CEO Uğur Şahin featured on Bloomberg's latest billionaires list | Ahval
5 things about BioNTech and the couple behind the COVID-19 vaccine with Pfizer - MarketWatch
3 Fragen an Maurice Kuhn, Student Assistant Corporate Social Responsibility, Biontech - #30u30
Covid vaccine profits mint 9 new pharma billionaires | CNN Business
Inequality.org - $2 billion: The net-worth gain for the three top shareholders in BioNTech, Pfizer's partner on Covid vaccine development. Moderna, Pfizer's Covid vaccine development rival, has so far this year minted
New vaccine billionaires gain wealth as Moderna, Pfizer shares soar
The CEO of Pfizer on Developing a Vaccine in Record Time
BioNTech - Wikipedia
